We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIMB icon
501
TIM SA
TIMB
$8.8B
$2.6M 0.02%
173,820
-95,778
-36% -$1.39M
MC icon
502
Moelis & Co
MC
$4.94B
$2.58M 0.02%
73,856
-99,399
-57% -$3.59M
EFSC icon
503
Enterprise Financial Services Corp
EFSC
$2.39B
$2.58M 0.02%
62,031
-6,546
-10% -$274K
TAL icon
504
TAL Education Group
TAL
$6.87B
$2.57M 0.02%
67,571
+27,748
+70% +$1M
SRRK icon
505
Scholar Rock
SRRK
$6.44B
$2.57M 0.02%
+162,071
New +$3M
BTG icon
506
B2Gold
BTG
$6.64B
$2.56M 0.02%
+844,477
New +$2.31M
STAA icon
507
STAAR Surgical
STAA
$1.21B
$2.56M 0.02%
87,244
+72,763
+502% +$2.1M
CENT icon
508
Central Garden & Pet Co
CENT
$2.8B
$2.54M 0.02%
117,985
+89,562
+315% +$1.98M
VREX icon
509
Varex Imaging
VREX
$523M
$2.54M 0.02%
+82,914
New +$2.53M
RPAY icon
510
Repay Holdings
RPAY
$327M
$2.51M 0.02%
+240,227
New +$2.48M
LEN icon
511
Lennar Class A
LEN
$21.2B
$2.5M 0.02%
53,348
+21,002
+65% +$1.05M
PPL
512
PPL Corp
PPL
$26.7B
$2.49M 0.02%
80,292
+67,946
+550% +$2.11M
CNK icon
513
Cinemark Holdings
CNK
$4.32B
$2.49M 0.02%
+68,849
New +$2.72M
AVTA
514
DELISTED
Avantax, Inc. Common Stock
AVTA
$2.48M 0.02%
81,730
+28,926
+55% +$952K
LYV icon
515
Live Nation Entertainment
LYV
$42.1B
$2.48M 0.02%
37,386
-52,969
-59% -$3.4M
TFC icon
516
Truist Financial
TFC
$64B
$2.45M 0.02%
49,869
+43,321
+662% +$2.12M
CW icon
517
Curtiss-Wright
CW
$25.5B
$2.43M 0.02%
19,133
-7,992
-29% -$921K
TEL icon
518
TE Connectivity
TEL
$62.6B
$2.42M 0.02%
+25,286
New +$2.28M
PSN icon
519
Parsons
PSN
$5.08B
$2.42M 0.02%
+65,646
New +$2.15M
BPY
520
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
$2.42M 0.02%
127,700
-493,544
-79% -$9.85M
RLJ icon
521
RLJ Lodging Trust
RLJ
$1.69B
$2.4M 0.01%
135,548
+132,448
+4,273% +$2.4M
WMT icon
522
Walmart Inc
WMT
$890B
$2.39M 0.01%
64,884
-106,314
-62% -$3.66M
NWG icon
523
NatWest
NWG
$76.4B
$2.39M 0.01%
+390,297
New +$2.56M
THO icon
524
Thor Industries
THO
$4.14B
$2.38M 0.01%
+40,797
New +$2.48M
TW icon
525
Tradeweb Markets
TW
$21.6B
$2.38M 0.01%
+54,254
New +$2.26M

Similar funds

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.